These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21920770)

  • 1. Role of IL-13 in systemic sclerosis.
    Fuschiotti P
    Cytokine; 2011 Dec; 56(3):544-9. PubMed ID: 21920770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis.
    Baraut J; Michel L; Verrecchia F; Farge D
    Autoimmun Rev; 2010 Dec; 10(2):65-73. PubMed ID: 20713187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production.
    Medsger TA; Ivanco DE; Kardava L; Morel PA; Lucas MR; Fuschiotti P
    Arthritis Rheum; 2011 Jun; 63(6):1738-47. PubMed ID: 21638273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell abnormalities in systemic sclerosis with a focus on Th17 cells.
    Brembilla NC; Chizzolini C
    Eur Cytokine Netw; 2012; 23(4):128-39. PubMed ID: 23360781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of systemic scleroderma: immunological aspects].
    Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L
    Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cells in systemic sclerosis.
    Fuschiotti P
    Immunol Res; 2011 Aug; 50(2-3):188-94. PubMed ID: 21717073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis.
    Chizzolini C
    Curr Opin Rheumatol; 2008 Nov; 20(6):707-12. PubMed ID: 18946333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis.
    Tsuji-Yamada J; Nakazawa M; Minami M; Sasaki T
    J Rheumatol; 2001 Jun; 28(6):1252-8. PubMed ID: 11409116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in the pathogenesis of systemic sclerosis.
    Sakkas LI
    Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
    Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
    Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of systemic sclerosis.
    Katsumoto TR; Whitfield ML; Connolly MK
    Annu Rev Pathol; 2011; 6():509-37. PubMed ID: 21090968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis.
    Ayano M; Tsukamoto H; Kohno K; Ueda N; Tanaka A; Mitoma H; Akahoshi M; Arinobu Y; Niiro H; Horiuchi T; Akashi K
    J Immunol; 2015 Aug; 195(3):892-900. PubMed ID: 26109642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T
    Cascio S; Medsger TA; Hawse WF; Watkins SC; Milcarek C; Moreland LW; Lafyatis RA; Fuschiotti P
    J Allergy Clin Immunol; 2018 Jul; 142(1):109-119.e6. PubMed ID: 29155097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased interleukin-17 production in patients with systemic sclerosis.
    Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
    Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.